Petros Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-0.00-0.01-0.030.08
Price/Sales ratio
0.070.030.010.01
Earnings per Share (EPS)
$-3.26$-2.49$-0.75$0.34

Historical Multiples (2018 – 2023)

2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-0.12-0.20-2.07-3.87-0.17-0.37-0.00-2.07
Price/Sales ratio
0.280.434.464.640.800.520.004.64
Price/Book Value ratio
-2.370.842.441.020.280.240.001.02
Price/Cash Flow ratio
0.492.68-2.79-3.05-0.37-0.40-0.00-2.79
Price/Free Cash Flow ratio
0.642.76-2.78-3.05-0.37-0.40-0.00-2.78
Price/Earnings Growth ratio
N/A0.000.020.06-0.000.00-0.000.06
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
25.41%52.32%57.67%79.52%61.79%71.98%80.34%57.67%
Operating Profit Margin
-54.44%-108.28%-180.78%-231.05%-264.44%-233.87%-283.10%-231.05%
Pretax Profit Margin
-231.19%-212.85%-230.27%-115.04%-334.40%-140.20%-285.64%-115.04%
Net Profit Margin
-231.10%-208.71%-215.34%-119.76%-451.22%-140.20%-285.65%-119.76%
Effective Tax Rate
0.04%1.94%6.48%-4.10%-34.93%N/A-0.04%-0.04%
Return on Assets
-48.54%-55.70%-29.46%-13.88%-83.39%-24.15%-63.67%-13.88%
Return On Equity
1931.44%-405.41%-117.84%-26.31%-161.87%-65.41%-76.08%-117.84%
Return on Capital Employed
-26.98%-97.71%-61.80%-49.56%-62.49%-59.14%-79.95%-49.56%
Liquidity Ratios
Current Ratio
N/AN/A0.61N/AN/AN/A2.360.61
Quick Ratio
0.240.240.600.961.811.741.890.60
Cash ratio
0.070.050.400.761.331.231.400.40
Days of Sales Outstanding
91.2361.04196.75114.73128.54139.55166.68166.68
Days of Inventory outstanding
226.02108.3368.60118.57289.38360.33475.9768.60
Operating Cycle
317.25169.37265.35233.31417.92499.89517.07265.35
Days of Payables Outstanding
61.02185.59505.991.04K287.99383.35460.611.04K
Cash Conversion Cycle
256.23-16.21-240.64-806.75129.93116.53-176.56-240.64
Debt Ratios
Debt Ratio
0.700.230.10N/A0.290.230.450.10
Debt Equity Ratio
-28.061.710.41N/A0.560.640.820.41
Long-term Debt to Capitalization
1.060.46N/AN/A0.330.350.30N/A
Total Debt to Capitalization
1.030.630.29N/A0.360.390.320.29
Interest Coverage Ratio
N/AN/A-13.05N/AN/AN/A-51.39N/A
Cash Flow to Debt Ratio
0.160.18-2.13N/A-1.35-0.95-1.96-2.13
Company Equity Multiplier
-39.787.273.991.891.942.701.821.89
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.570.16-1.60-1.51-2.13-1.30-2.32-1.51
Free Cash Flow / Operating Cash Flow Ratio
0.760.971.0011111
Cash Flow Coverage Ratio
0.160.18-2.13N/A-1.35-0.95-1.96-2.13
Short Term Coverage Ratio
0.410.37-2.13N/A-11.74-6.59-21.55N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/A